Brand
Taro Pharmaceuticals Inc.
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Taro Pharmaceuticals Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2023-11-15FDA-DrugClass IIIHydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1
Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Get notified about new Taro Pharmaceuticals Inc. recalls
Free weekly digest. We email when a new federal recall affects Taro Pharmaceuticals Inc. or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state